blinq™ 视力筛查仪在弱视和斜视检测中的应用
本研究前瞻性评估 blinq(Rebion Inc)筛查仪在儿童眼科门诊中检测弱视和斜视的效果。267 名平均年龄 6.3 岁儿童在盲法检查前接受 blinq 筛查,结果显示检测弱视或任何恒定性斜视的敏感度为 87.5%、特异度为 51.3%,采用「适当转诊金标准」后敏感度升至 91.3%、特异度升至 63.2%。作者结论支持 blinq 作为筛查设备用于检测儿童弱视和斜视。
要点
- blinq 检测弱视或恒定性斜视的敏感度为 87.5%(78.2%-93.8%),特异度为 51.3%(43.9%-58.7%)。
- 采用「适当转诊金标准」后敏感度升至 91.3%,特异度升至 63.2%。
- 44 名(16%)儿童 blinq 超时并被自动纳入转诊。
核心结论
- 作者结论支持将 blinq 作为筛查设备用于检测儿童弱视和斜视。
研究设计与样本
- 前瞻性临床效度分析,基于敏感度和特异度评估筛查设备。
- 267 名至小儿眼科门诊就诊的儿童在儿科眼科医师盲法检查前接受 blinq 筛查,平均年龄 6.3 岁。
主要发现
- blinq 检测弱视或任何恒定性斜视的敏感度为 87.5%(78.2%-93.8%),特异度为 51.3%(43.9%-58.7%)。
- 采用「适当转诊金标准」标准(纳入间歇性斜视和高度屈光不正儿童)后,敏感度升至 91.3%,特异度升至 63.2%。
- 44 名(16%)儿童 blinq 超时并被纳入自动转诊。
关键数值与推荐
- 敏感度 87.5%(78.2%-93.8%),特异度 51.3%(43.9%-58.7%),针对弱视或任何恒定性斜视。
- 采用「适当转诊金标准」后敏感度 91.3%、特异度 63.2%。
临床怎么用
- 作者结论支持将 blinq 作为筛查设备用于检测儿童弱视和斜视。
局限性
- 44 名(16%)儿童 blinq 超时并被纳入自动转诊。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The blinq (Rebion Inc) is a new screening device designed to directly detect amblyopia and strabismus rather than amblyopia risk factors. We performed an independent assessment of the effectiveness of the blinq in detecting amblyopia and strabismus. DESIGN: Prospective clinical validity analysis of a screening device based on sensitivity and specificity. METHODS: Children presenting for examination in the pediatric ophthalmology clinic underwent screening with the blinq before examination by a pediatric ophthalmologist blinded to the screening results. Results of the blinq and examination findings of strabismus or amblyopia were compared. RESULTS: In our cohort of 267 children with an average age of 6.3 years, the sensitivity of the blinq to detect amblyopia or any constant strabismus was 87.5% (78.2%-93.8%) and specificity was 51.3% (43.9%-58.7%). Using the previously described "appropriate referral gold standard" criteria, including children with intermittent strabismus and high refractive error, the sensitivity increased to 91.3% and the specificity to 63.2%. We found a high number of children (44 [16%]) upon whom the blinq timed out and were included as automatic referrals. CONCLUSIONS: Our results support use of the blinq as a screening device to detect amblyopia and strabismus in children.
引用
- Monahan SR, Smith SM, Gammeltoft ET, et al. The blinq™ Vision Screener in Detection of Amblyopia and Strabismus. Am J Ophthalmol. 2023. PMID: 36682517. doi:10.1016/j.ajo.2023.01.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。